Avista buys another pharma contracting biz

Contract drug developer Avista Pharma Solutions bought the manufacturing, development and animal health services business of rival Scynexis, building up its capacity to take a larger share of an expanding market. Under the deal, Avista picks up a development and manufacturing facility in Durham, NC, with plans to hire "substantially all" of the Scynexis employees already there, the company said, not disclosing financial details. The acquisition comes a month after Avista bought Array BioPharma's ($ARRY) chemistry, manufacturing and controls business, part of a broader effort to expand its capabilities. Avista is a subsidiary of pharma contractor Accuratus Lab Services, which is owned by the private equity firm Ampersand Capital Partners. More

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.